Meeting of the National Vaccine Advisory Committee, 27329 [2015-11476]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 80, Number 92 (Wednesday, May 13, 2015)]
[Notices]
[Page 27329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11476]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
on June 9-10, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at https://www.hhs.gov/nvpo/nvac. 
Participants may also register by emailing nvpo@hhs.gov or by calling 
202-690-5566 and providing their name, organization, and email address.

DATES: The meeting will be held on June 9-10, 2015. The meeting times 
and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac as soon as they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, 
DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The June NVAC meeting will include the presentation of 
recommendations from several of the NVAC working groups for 
deliberation and vote. The Vaccine Confidence Working Group will 
present their report and recommendations for measuring and evaluating 
how confidence in vaccines impacts the optimal use of recommended 
childhood vaccines in the United States. Following an update on current 
efforts by national stakeholders to improve Human Papilloma Virus (HPV) 
vaccine uptake among adolescents, the HPV working group will also 
present their report and recommendations identifying existing best 
practices to increase the use of the HPV vaccine in young adolescents. 
NVAC will review analyses and proposed recommendations on how vaccines 
could play more prominently in efforts described in the President's 
National Strategy and Action Plan to Combat Antibiotic Resistant 
Bacteria.
    An overview of the Vaccine Safety Research Agenda that was released 
on the NVPO Web site in February 2015 will also be provided. The 
Vaccine Safety Research Agenda outlines the efforts of federal agencies 
on vaccine safety and the ongoing and planned associated scientific 
activities and interagency coordination that contribute to the safety 
system. Informational presentations will also be provided to inform 
NVAC members of recent developments impacting the vaccine landscape 
including Congressional efforts to support the research and development 
of new vaccine products through the 21st Century Cures Initiative. More 
information on the meeting agenda will be posted prior to the meeting 
on the NVAC Web site: https://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office (nvpo@hhs.gov) at least five 
business days prior to the meeting.

    Dated: May 4, 2015.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2015-11476 Filed 5-12-15; 8:45 am]
 BILLING CODE 4150-44-P